12% of spice samples tested in India fail quality checks
What's the story
Almost 12% of tested spice samples in India have failed to meet the required quality and safety standards, as per data obtained by Reuters. The information was sourced from tests conducted by the Food Safety and Standards Authority of India (FSSAI), following concerns about contamination risks in two popular brands. This development comes after Hong Kong suspended sales of certain blends from the MDH and Everest brands in April, due to high pesticide levels.
Regulatory action
FSSAI's response to failed spice samples
FSSAI has been actively inspecting, sampling, and testing mixed spice blends in response to these concerns. The data revealed that out of 4,054 samples tested between May and early July, 474 did not meet the set quality and safety parameters. However, the FSSAI did not provide a breakdown by brands for the spices tested but confirmed that necessary action is being taken against companies involved.
Global impact
International scrutiny and brand assurances
Following Hong Kong's decision, UK tightened controls on all spice imports from India. Additionally, New Zealand, the US, and Australia have stated they are investigating issues related to these brands. Despite this scrutiny, both MDH and Everest have assured that their products are safe for consumption. These brands are among the most popular in India - a global leader in spice production, consumption, and export with significant market presence in Europe, Asia, and North America.
Economic overview
India's spice market and export performance
India's domestic spice market was estimated to be worth $10.44 billion in 2022, as per Zion Market Research. The country also set a record for its exports of spices and spice products, touching $4.46 billion in the fiscal year that ended in March. This economic data underscores the significant role India plays in the global spice trade, despite recent quality and safety concerns raised by international partners.